ArticleJournal of hematology & oncology2021

Targeting B7-H3 via chimeric antigen receptor T cells and bispecific killer cell engagers augments antitumor response of cytotoxic lymphocytes.

Jie Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.